Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
05/30/2013 | US20130137637 Peptides for promoting angiogenesis and an use thereof |
05/30/2013 | US20130137634 Compounds and compositions for ossification and methods related thereto |
05/30/2013 | US20130137633 mTOR KINASE-ASSOCIATED PROTEINS |
05/30/2013 | US20130137629 Combination treatment for metabolic disorders |
05/30/2013 | US20130137118 Integrin heterodimer and a subunit thereof |
05/30/2013 | US20130136796 Acellular Bioabsorbable Tissue Regeneration Matrices |
05/30/2013 | US20130136774 Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition |
05/30/2013 | US20130136769 Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
05/30/2013 | US20130136762 Modified surface antigen |
05/30/2013 | US20130136760 Streptococcus pyogenes antigens and corresponding dna fragments |
05/30/2013 | US20130136751 Methods, Compositions and Kits Relating to Chitnases and Chitnase-Like Molecules and Inflammation Disease |
05/30/2013 | US20130136740 Methods of treating cancer |
05/30/2013 | US20130136738 Methods of Treating Glucose Metabolism Disorders |
05/30/2013 | US20130136729 Compositions and methods for targeting and treating diseases and injuries using adeno-associated virus vectors |
05/30/2013 | US20130136726 Method for detection of predisposition to atherosclerosis, coronary heart disease and related conditions |
05/30/2013 | US20130136718 Targeting interferon-lambda with antibodies potently enhances anti-tumor and anti-viral activities |
05/30/2013 | US20130136717 Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth |
05/30/2013 | US20130136700 Poly-hapten with topical hormone alopecia hair regrowth system |
05/30/2013 | US20130136692 Molecular signature of cancer |
05/30/2013 | US20130135979 Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
05/30/2013 | CA2856593A1 Polypeptides having lysozyme activity and polynucleotides encoding same |
05/30/2013 | CA2854255A1 Mutations of histone proteins associated with proliferative disorders |
05/30/2013 | CA2851210A1 Combination therapy using anti-cd20 antibody and human il-15 |
05/29/2013 | EP2597163A1 The large form of human 2',5'-oligoadenylate synthetase OAS3 for preventing or treating infection with positive-sense single-stranded RNA viruses |
05/29/2013 | EP2597105A1 A conjugate comprising angiostatin or its fragment, the method for producing the conjugate and use thereof |
05/29/2013 | EP2596813A1 Sheet preparation for tissue adhesion |
05/29/2013 | EP2596800A1 Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia |
05/29/2013 | EP2596799A1 Methods and compositions related to inhibition of viral entry |
05/29/2013 | EP2596023A2 Compositions and methods featuring il-6 and il-21 antagonists |
05/29/2013 | EP2596008A1 Tubulysin analogues |
05/29/2013 | EP2595656A1 Prevention and treatment of pain using monoclonal antibodies and antibody fragments to lysophosphatidic acid |
05/29/2013 | EP2595651A2 Mannose receptor c type 1 (mrc1) codon optimized cell line and uses thereof |
05/29/2013 | EP2595650A2 Manufacture of active highly phosphorylated human n-acetylgalactosamine-6-sulfatase and uses thereof |
05/29/2013 | EP2595649A1 An ancestral serine protease coagulation cascade exerts a novel function in early immune defense |
05/29/2013 | EP2595648A2 Novel long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity |
05/29/2013 | EP2595647A1 N-terminal modified fgf21 compounds |
05/29/2013 | EP2595646A2 Bhlh proteins and their use as drugs |
05/29/2013 | EP2595645A2 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom |
05/29/2013 | EP2595644A1 Amyloid-beta clearance |
05/29/2013 | EP2595624A2 Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects |
05/29/2013 | EP2595496A1 Antimicrobial peptide, branched forms thereof and their use in the treatment of bacteria infections |
05/29/2013 | CN1911965B Binding domain-immunoglobulin fusion proteins |
05/29/2013 | CN1525866B Treatment using neublastin polypeptides |
05/29/2013 | CN103124789A Polypeptides for use in the deconstruction of cellulose |
05/29/2013 | CN103124739A Novel glucagon like peptide analogs, composition, and method of use |
05/29/2013 | CN103124562A FGF21 analogues and derivatives |
05/29/2013 | CN103124561A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
05/29/2013 | CN103124554A Pharmaceutical composition |
05/29/2013 | CN103122347A Lyase for killing staphylococcus and application of lyase |
05/29/2013 | CN103122031A Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
05/29/2013 | CN103122030A Hirulog as well as preparation method and application thereof |
05/29/2013 | CN103122025A Small molecule-polypeptide conjugate for inhibiting human immunodeficiency virus (HIV) infection |
05/29/2013 | CN103122024A Artificially designed HIV (human immunodeficiency virus)-infection-resisting polypeptide, composition and application |
05/29/2013 | CN103120733A Medicine for treating myocarditis |
05/29/2013 | CN103120653A Oral pharmaceutical composition |
05/29/2013 | CN103120644A Amphiphilic segmented copolymer micelle of macromolecules of biologically functional protein and preparation and application thereof |
05/29/2013 | CN102719397B Mesenchymal stem cell and application thereof in resisting HIV-1 (human immunodeficiency virus) |
05/29/2013 | CN102492022B Novel anti-senile dementia lead compound |
05/29/2013 | CN102399284B Fox growth hormone releasing hormone cDNA and its application |
05/29/2013 | CN102399283B Mink growth hormone releasing hormone cDNA and application thereof |
05/29/2013 | CN102370987B Injection liposome entrapping antineoplastic pharmaceutical composition |
05/29/2013 | CN102366410B Argatroban liposome injection |
05/29/2013 | CN102260325B Antibacterial peptide NX-16, and preparation method and application thereof |
05/29/2013 | CN102178928B Application of cobra venom neurotoxin in drugs for treating ametropia |
05/29/2013 | CN101815525B Anti-hypertensive agent |
05/29/2013 | CN101802185B Truncated secretory aspartyl proteinase 2 |
05/29/2013 | CN101798346B Long-acting recombinant human tissue factor pathway inhibitor expressed by yeast |
05/29/2013 | CN101646767B Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
05/29/2013 | CN101636168B Sp35 antibodies and uses thereof |
05/29/2013 | CN101492493B Process for obtaining high efficiency human albumin for use in detoxification therapy |
05/29/2013 | CN101480490B Process for obtaining a concentrate of von Willebrand factor or a complex of factor VIII/von Willebrand factor and use of the same |
05/29/2013 | CN101454440B Probiotic strain and antimicrobial peptide derived therefrom |
05/29/2013 | CN101389652B T cell receptors which specifically bind to VYGFVRACL-HLA-A24 |
05/29/2013 | CN101217972B Method for fostering bone formation and preservation |
05/29/2013 | CN101184474B A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
05/28/2013 | US8450470 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
05/28/2013 | US8450465 Methods of isolating peptides using surface-free affinity purification |
05/28/2013 | US8450459 IL-21 derivatives and variants |
05/28/2013 | US8450458 Recombinant TAT-HOXB4H protein for use as a stimulant of hematopoiesis in vivo |
05/28/2013 | US8450455 cRGD peptide derivative and its manufacture, and implant having a coating containing a cRGD peptide derivative |
05/28/2013 | US8450347 Administering a protein fraction, digestible carbohydrates, and a combination of folate, and one of vitamin B6 and vitamin B12. |
05/28/2013 | US8450298 Aminoalcohol lipidoids and uses thereof |
05/28/2013 | US8450289 Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis |
05/28/2013 | US8450288 For introduction of a disc prosthesis or implant; involves providing substance(s) beneficial to the intervertebral disc through a cannulated element |
05/28/2013 | US8450285 Immunoregulatory peptides and methods of use |
05/28/2013 | US8450284 Coiled-coil lipopeptide helical bundles and synthetic virus-like particles |
05/28/2013 | US8450283 Composition for treating cancer and use thereof |
05/28/2013 | US8450282 Anionic polymer, polyion complex and ternary polymer composite using anionic polymer, and pharmaceutical composition |
05/28/2013 | US8450281 Non-immunosuppressive cyclosporin for treatment of Ullrich congenital muscular dystrophy |
05/28/2013 | US8450280 Activation of peptide prodrugs by hK2 |
05/28/2013 | US8450278 MUC18 targeting peptides |
05/28/2013 | US8450276 Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability |
05/28/2013 | US8450275 TFPI inhibitors and methods of use |
05/28/2013 | US8450274 DKK2 protein and use thereof |
05/28/2013 | US8450273 Fusion proteins of collagen-binding domain and parathyroid hormone |
05/28/2013 | US8450272 Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes |
05/28/2013 | US8450271 Peptide-based scaffolds for cartilage regeneration and methods for their use |
05/28/2013 | US8450269 Long-acting growth hormone and methods of producing same |
05/28/2013 | US8450268 Methods of using macrocyclic modulators of the ghrelin receptor |
05/28/2013 | US8450266 Analogues of glucose-dependent insulinotropic polypeptide |